How To Use HCPCS Code C2616

HCPCS code C2616 describes a brachytherapy source that is non-stranded and contains yttrium-90. This code is used to identify the specific type of brachytherapy source being used in a medical procedure. Brachytherapy is a form of radiation therapy where radioactive sources are placed directly into or near the tumor site to deliver targeted radiation treatment. The use of yttrium-90 in the brachytherapy source indicates that it emits beta radiation, which is effective in treating certain types of cancer.

1. What is HCPCS C2616?

HCPCS code C2616 is used to identify a specific type of brachytherapy source that contains yttrium-90. This code is important for medical coders and billers to accurately document and bill for the use of this particular brachytherapy source in a medical procedure.

2. Official Description

The official description of HCPCS code C2616 is “Brachytherapy source, non-stranded, yttrium-90, per source.” The short description for this code is “Enteral supp not otherwise c.” This description provides a clear and concise explanation of the brachytherapy source being used and its purpose.

3. Procedure

1. The provider begins by preparing the patient for the brachytherapy procedure.
2. The brachytherapy source containing yttrium-90 is then inserted into or near the tumor site.
3. The source remains in place for a specific period of time, delivering targeted radiation treatment to the tumor.
4. After the desired treatment duration, the brachytherapy source is removed.
5. The patient is monitored and may require follow-up care or additional treatments.

4. When to use HCPCS code C2616

HCPCS code C2616 should be used when a healthcare provider is performing a brachytherapy procedure using a non-stranded brachytherapy source that contains yttrium-90. It is important to ensure that the specific criteria for using this code are met in order to accurately document and bill for the procedure.

5. Billing Guidelines and Documentation Requirements

When billing for the brachytherapy procedure using HCPCS code C2616, healthcare providers need to document the specific details of the procedure, including the type of brachytherapy source used (non-stranded, yttrium-90), the number of sources used, and the duration of the treatment. It is also important to include any relevant supporting documentation, such as medical records and treatment plans, to justify the use of this code.

6. Historical Information and Code Maintenance

HCPCS code C2616 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996, indicating that it has been in use for a significant period of time. There have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code.

7. Medicare and Insurance Coverage

HCPCS code C2616 is eligible for coverage by Medicare and other insurance providers. The pricing indicator code 57 indicates that this code is priced by other carriers, and the multiple pricing indicator code A indicates that it is not applicable as HCPCS priced under one methodology. Healthcare providers should refer to the Medicare Carriers Manual Reference Section Number 2130 for specific guidance on billing and reimbursement for this code.

8. Examples

Here are five examples of when HCPCS code C2616 should be billed:

1. A patient with prostate cancer undergoes brachytherapy using a non-stranded brachytherapy source containing yttrium-90.
2. A patient with liver cancer receives brachytherapy treatment using a non-stranded brachytherapy source containing yttrium-90.
3. A patient with breast cancer undergoes brachytherapy using a non-stranded brachytherapy source containing yttrium-90.
4. A patient with cervical cancer receives brachytherapy treatment using a non-stranded brachytherapy source containing yttrium-90.
5. A patient with lung cancer undergoes brachytherapy using a non-stranded brachytherapy source containing yttrium-90.